KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

LEUKEMIA

not available

10.1038/s41375-019-0444-6

WOS:000479118400025

http://hdl.handle.net/11368/2955876

info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85063040196

https://www.nature.com/articles/s41375-019-0444-6

open access

license:creative commons

license:creative commons

license uri:http://creativecommons.org/licenses/by/4.0/

license uri:http://creativecommons.org/licenses/by/4.0/

https://arts.units.it/bitstream/11368/2955876/1/Vendramini_Leukemia_2019.pdf